Vyome Holdings (HIND) EPS (Basic) Growth (5y) (2022 - 2026)
Vyome Holdings (HIND) EPS (Basic) Growth (5y) (2022 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.79 Bn | 130.93 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.99 Bn | 78.00 Bn | 3.93 Bn |
| 3 | Argenx Se | 65.26 Bn | 60.07 Bn | 1.37 Bn |
| 4 | Moderna | 56.04 Bn | 50.91 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 42.05 Bn | 36.95 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.71 Bn | 28.40 Bn | 992.69 Mn |
| 7 | BioNTech SE | 27.66 Bn | 9.26 Bn | 668.28 Mn |
| 8 | Insmed | 27.50 Bn | 26.33 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.35 Bn | 26.52 Bn | - |
| 10 | Vyome Holdings | 16.00 Mn | 8.11 Mn | 11,658.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 93.59% |
| Mar 31, 2026 | 94.67% |
| Dec 31, 2025 | 94.17% |
| Sep 30, 2025 | 91.15% |
| Jun 30, 2025 | 88.24% |
| Mar 31, 2025 | 14.87% |
| Dec 31, 2024 | 79.55% |
| Sep 30, 2024 | 78.82% |
| Jun 30, 2024 | 82.99% |
| Mar 31, 2024 | 81.87% |
| Dec 31, 2023 | 79.36% |
| Sep 30, 2023 | 72.70% |
| Jun 30, 2023 | 73.86% |
| Mar 31, 2023 | 73.50% |
| Dec 31, 2022 | 46.26% |
| Sep 30, 2022 | 87.40% |
| Jun 30, 2022 | 87.87% |
| Mar 31, 2022 | 58.49% |